Hunter Puterbaugh, 22, had just arrived from Ohio and was staying in a Midtown hotel waiting for his lease to start when the ...

New York City for decades has allowed developers to hire third-party inspectors to certify the safety of projects like 235 ...

Republican nominee for governor Bruce Blakeman caused a stir with a recent AI-generated ad targeting his opponent, incumbent ...

The Episcopal Church s Church Center building at 815 Second Avenue in Manhattan was among several buildings evacuated Tuesday ...

Pfizer’s high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. The pharma giant announced Monday that sigvotatug vedotin, the first new ADC to read out pivotal data following its ...

The big headline with Pfizer is that it will have to deal with revenue declines from drugs facing patent expirations over the next few years. That's normal, since new drugs are given a time-limited ...

Pfizer (PFE) on Thursday reaffirmed its 2026 outlook after announcing that its Chief Financial Officer, Dave Denton, will resign in August, and Cecile Guegan, its senior vice president of finance for ...

For this story, Boodman obtained email chains between Pfizer and health officials and conducted interviews with 10 state health departments, eight local health agencies, six health system pharmacists, ...

Pfizer's 6.7% yield is covered by free cash flow, but negative ROIC and net debt above 3x EBITDA keep PFE a Hold, not a Buy. Analysts target PFE at $29, while Polymarket prices in 12% downside to $23, ...

NEW YORK, June 6 (Reuters) - Pfizer (PFE.N), opens new tab presented data on Saturday that showed a monthly dose of an experimental obesity drug it acquired through ‌its purchase of Metsera last year ...

Pfizer PFE reported 5% top-line growth but an 18% decline in adjusted diluted EPS, mostly due to royalty expenses weighing on its gross margin. Management maintained its full-year guidance for $59.5 ...

Pfizer posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched and acquired products showed growth. Older top-selling drugs, including its ...